Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 19(5): e0301688, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38768145

RESUMO

Swine atrophic rhinitis is a disease caused by Pasteurella multocida and Bordetella bronchiseptica that affects pigs. Inactivated vaccines containing the toxins produced by Pasteurella multocida and Bordetella bronchiseptica have been widely used for the prevention of swine atrophic rhinitis. The efficacy of a vaccine is correlated with the amount of antigen present; however, the protective toxin of P. multocida bound to aluminum hydroxide, which is used as an adjuvant, can hinder the monitoring of the antigen concentration in the vaccine. This study assessed the applicability of a dot immunoassay as an antigen quantification method using monoclonal antibodies. This quantification method was able to detect the antigen with high specificity and sensitivity even when the antigen was bound to the adjuvant, and its application to vaccine products revealed a correlation between the amount of antigen present in the vaccine and the neutralizing antibody titers induced in pigs. The antigen quantification method presented in this study is a simple and sensitive assay capable of quantifying the amount of antigen present in a vaccine that can be used as an alternative quality control measure.


Assuntos
Adjuvantes Imunológicos , Hidróxido de Alumínio , Antígenos de Bactérias , Vacinas Bacterianas , Pasteurella multocida , Rinite Atrófica , Doenças dos Suínos , Animais , Pasteurella multocida/imunologia , Suínos , Rinite Atrófica/imunologia , Rinite Atrófica/prevenção & controle , Rinite Atrófica/microbiologia , Vacinas Bacterianas/imunologia , Antígenos de Bactérias/imunologia , Doenças dos Suínos/prevenção & controle , Doenças dos Suínos/microbiologia , Doenças dos Suínos/imunologia , Bordetella bronchiseptica/imunologia , Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/imunologia , Infecções por Pasteurella/prevenção & controle , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/imunologia , Anticorpos Neutralizantes/imunologia
2.
Vet Res ; 54(1): 29, 2023 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-36973816

RESUMO

Porcine edema disease (ED) is an enterotoxaemia that frequently occurs in 4-12 week-old piglets and results in high mortality. ED is caused by Shiga toxin 2e (Stx2e), produced by host-adapted Shiga toxin-producing Escherichia coli (STEC) strains. We constructed a recombinant protein in which the B subunit of Stx2e (Stx2eB) was linked to Cartilage Oligomeric Matrix Protein (COMP)'s pentameric domain to enhance antigenicity to induce neutralizing antibodies against Stx2e. We evaluated the efficacy of this antigen as a vaccine on the farm where ED had occurred. The suckling piglets were divided into two groups. The pigs in the vaccinated group were intramuscularly immunized with the vaccine containing 30 µg/head of Stx2eB-COMP at 1 and 4 weeks of age. The control pigs were injected with saline instead of the vaccine. The neutralizing antibody titer to Stx2e, mortality, clinical score, and body weight was evaluated up to 11 weeks after the first vaccination. In the vaccinated group, the Stx2e neutralizing antibody was detected 3 weeks after the first vaccination, its titer increased during the following weeks. The antibody was not detected in the control group during the test period. The STEC gene was detected in both groups during the test period, but a typical ED was observed only in control pigs; the mortality and clinical score were significantly lower in the vaccinated group than in the control group. These data indicate that the pentameric B subunit vaccine is effective for preventing ED and offers a promising tool for pig health control.


Assuntos
Antitoxinas , Edematose Suína , Infecções por Escherichia coli , Escherichia coli Shiga Toxigênica , Doenças dos Suínos , Animais , Suínos , Toxina Shiga II/genética , Infecções por Escherichia coli/prevenção & controle , Infecções por Escherichia coli/veterinária , Edematose Suína/prevenção & controle , Anticorpos Neutralizantes , Vacinas de Subunidades Antigênicas , Edema/prevenção & controle , Edema/veterinária , Doenças dos Suínos/prevenção & controle
3.
Avian Dis ; 62(2): 210-217, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29944406

RESUMO

We identified novel linear epitopes on the infectious bronchitis virus (IBV) spike S2 region. The conformational structure of the IBV spike protein was predicted from a homologous protein, human coronavirus NL63 spike. Although the obtained structure was incomplete, most of the IBV spike protein structure was predicted; the N-terminus of the S1 region could not be predicted due to its variability. In the model, the region located in the proximity of the fusion peptide appeared to be well conserved, and we evaluated the antigenicity of these domains, which are involved in the membrane fusion machinery. Western blotting revealed that IBV TM86 spike residues 686-723 were antigenic. Epitope mapping analysis using synthesized peptides revealed that IBV TM86 spike 669-685 (SNFSTGAFNISLLLTPP), 686-697 (SNPRGRSFIEDL), and 692-703 (SFIEDLLFTSVE) residues were major linear epitopes; two identified epitopes (686-697 and 692-703) were covered by the fusion peptide, and the other epitope (669-685) was adjacent to the fusion peptide. Although the identified epitopes are identically located as the neutralizing epitope in severe acute respiratory syndrome coronavirus, the recombinant protein that includes those epitopes could not elicit neutralizing antibodies against IBV. This is the first report describing IBV spike S2 epitopes located in the proximity of the fusion peptide, and it is suggested that the spike fusion machinery of IBV may differ from that of severe acute respiratory syndrome coronavirus, or, alternatively, IBV may have another mechanism to penetrate the cell membrane.


Assuntos
Infecções por Coronavirus/veterinária , Epitopos/imunologia , Vírus da Bronquite Infecciosa/imunologia , Doenças das Aves Domésticas/virologia , Glicoproteína da Espícula de Coronavírus/química , Glicoproteína da Espícula de Coronavírus/imunologia , Motivos de Aminoácidos , Animais , Anticorpos Neutralizantes/imunologia , Anticorpos Antivirais/imunologia , Galinhas , Infecções por Coronavirus/imunologia , Infecções por Coronavirus/virologia , Mapeamento de Epitopos , Epitopos/química , Epitopos/genética , Vírus da Bronquite Infecciosa/química , Vírus da Bronquite Infecciosa/genética , Doenças das Aves Domésticas/imunologia , Glicoproteína da Espícula de Coronavírus/genética
4.
Virus Res ; 208: 164-70, 2015 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-26113306

RESUMO

We evaluated the antigenicity of recombinant infectious bronchitis virus (IBV) S1 protein expressed in mammalian cells. Recombinant S1 was expressed as a secreted protein fused with a trimerization motif peptide, then purified using Ni Sepharose. The purified protein was analyzed by Western blotting, mixed with oil adjuvant, and administered to 29-day-old specific-pathogen-free chickens. Six weeks after immunization, anti-IBV neutralizing titer and anti-S1 ELISA titer were determined; immunized chickens then were inoculated with IBV via the trachea and ciliary activity was observed. Results showed that the recombinant S1 protein was highly glycosylated, and the neutralizing antigenicity of recombinant S1 protein was lower than that of inactivated virus. However, anti-S1 ELISA indicated that the recombinant S1 protein induced antibodies against S1. These results suggest that the recombinant S1 may retain non-neutralizing epitopes but have unnatural glycosylation pattern and conformation, resulting in lacking neutralizing conformational epitopes. In conclusion, the neutralizing antigenicity of recombinant S1 protein expressed from mammalian cells was decreased, and was not sufficient to induce neutralizing antibodies.


Assuntos
Infecções por Coronavirus/veterinária , Vírus da Bronquite Infecciosa/imunologia , Doenças das Aves Domésticas/virologia , Glicoproteína da Espícula de Coronavírus/imunologia , Animais , Anticorpos Neutralizantes/imunologia , Anticorpos Antivirais/imunologia , Galinhas , Infecções por Coronavirus/imunologia , Infecções por Coronavirus/virologia , Imunização , Vírus da Bronquite Infecciosa/genética , Doenças das Aves Domésticas/imunologia , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Organismos Livres de Patógenos Específicos , Glicoproteína da Espícula de Coronavírus/genética , Vacinas Virais/administração & dosagem , Vacinas Virais/genética , Vacinas Virais/imunologia
5.
Brain Res ; 1102(1): 63-70, 2006 Aug 02.
Artigo em Inglês | MEDLINE | ID: mdl-16797494

RESUMO

Postoperative ileus (POI) is often exacerbated by opioid analgesic use during and following surgery, since mu opioid receptor activation results in a further delay of gastrointestinal (GI) transit. The effects of alvimopan, a novel, selective, and peripherally acting mu opioid receptor antagonist, and the reference compound methylnaltrexone, upon POI were investigated in rats. Under isoflurane anesthesia, POI was induced by laparotomy with intestinal manipulation. Immediately after the surgery, the rats received (51)Cr by gavage. Three hours after the surgery, the rats were sacrificed and GI transit was estimated using the geometric center (GC) of (51)Cr. Alvimopan (0.1-3 mg/kg) or methylnaltrexone (100 mg/kg) were administered by gavage either before or after the surgery, with or without morphine administration (1 mg/kg). GI transit was delayed by intestinal manipulation (GC = 2.92 +/- 0.17). Alvimopan (1 and 3 mg/kg) significantly reversed this delayed GI transit when administered 45 min prior to surgery. However, the effects of alvimopan were less pronounced when administered following surgery. Morphine administration further delayed GI transit induced by intestinal manipulation (GC = 1.97 +/- 0.11). Under these conditions, alvimopan (1 and 3 mg/kg) also significantly improved delayed GI transit when administered before surgery. Methylnaltrexone was inactive under all experimental conditions. These data suggest that mu opioid receptors play a role in the pathogenesis of POI, and that the clinical benefit reported to be afforded by alvimopan may be in part mediated via inhibition of an endogenous opioid release as well as blockade of the unwanted GI actions of analgesic agents.


Assuntos
Trânsito Gastrointestinal/efeitos dos fármacos , Íleus/tratamento farmacológico , Antagonistas de Entorpecentes/uso terapêutico , Piperidinas/uso terapêutico , Complicações Pós-Operatórias/tratamento farmacológico , Analgésicos Opioides/efeitos adversos , Análise de Variância , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Íleus/etiologia , Laparotomia/efeitos adversos , Masculino , Naltrexona/administração & dosagem , Naltrexona/análogos & derivados , Compostos de Amônio Quaternário/administração & dosagem , Ratos , Ratos Sprague-Dawley
6.
J Smooth Muscle Res ; 41(3): 163-74, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16006749

RESUMO

Recently an essential role of interstitial cells of Cajal (ICC) within myenteric plexus (ICC-MY) was suggested in ascending contraction and descending relaxation in the mouse ileum. The role of ICC in these neural reflexes was examined in the distal colonic segments prepared from the wild type and c-kit mutant, W/W(V) mice, in the present study. Localized distension of the segments from the wild type mice by using a small balloon resulted in ascending contraction and descending relaxation. In the segments from the mutant mice, localized distension also induced these neural reflexes similar to those observed in the wild type mice. Immunohistochemical examination demonstrated that ICC-MY and ICC present in muscle layers (ICC-IM) were severely disrupted in the mutant mouse, but only ICC, present within submucosal plexus (ICC-SMP), remained unchanged. In the small strips with ICC-SMP absent prepared from the mutant mouse, electrical field stimulation induced contraction or relaxation in the absence or presence of atropine, respectively. It was suggested that ICC have no important role in the ascending and descending neural reflexes in the mouse distal colon, this is in direct contrast to the role of ICC-MY in the ileum.


Assuntos
Colo/fisiopatologia , Motilidade Gastrointestinal , Plexo Mientérico/anormalidades , Plexo Mientérico/patologia , Animais , Atropina/farmacologia , Cateterismo , Estimulação Elétrica , Motilidade Gastrointestinal/efeitos dos fármacos , Técnicas In Vitro , Camundongos , Camundongos Mutantes , Mutação , Plexo Mientérico/fisiopatologia , Proteínas Proto-Oncogênicas c-kit/genética , Reflexo , Plexo Submucoso/patologia
7.
J Smooth Muscle Res ; 41(1): 49-60, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15855739

RESUMO

Our previous study showed that impairment of ascending and descending neural reflexes in the ileum of the c-kit mutant, W/W(V), mice is due to a loss of interstitial cells of Cajal present at the myenteric plexus region (ICC-MY) in the mutant. In the present study, cholinergic interneurons were thought to be involved in these pathways, since hexamethonium, an antagonist of the nicotinic ACh receptor, significantly inhibited both neural reflexes in wild type mice. Therefore, we examined whether the loss of ICC-MY affects cholinergic interneurons involved in these pathways. Immunohistochemistry with anti-choline acetyltransferase revealed that there was no difference in the numbers of immunopositive cells in the myenteric plexus region between the wild type and mutant mice. In addition, there was no difference in the extent of spontaneous and EFS-evoked ACh release from longitudinal muscle with myenteric plexus preparations between the wild type and mutant mice. Exogenously added nicotine induced contraction or relaxation of ileal circular muscle in the absence or presence of atropine, respectively, to a similar extent in both the wild type and mutant mice. These results suggest that loss of ICC-MY resulted in an impairment of the ascending and descending reflex pathways at the step before activation of cholinergic interneurons.


Assuntos
Colina O-Acetiltransferase/análise , Íleo/inervação , Interneurônios/fisiologia , Contração Muscular/fisiologia , Músculo Liso/fisiologia , Plexo Mientérico/fisiologia , Proteínas Proto-Oncogênicas c-kit/genética , Animais , Imuno-Histoquímica , Técnicas In Vitro , Camundongos , Camundongos Mutantes , Nicotina/farmacologia , Proteínas Proto-Oncogênicas c-kit/análise , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...